Sarah B.

Sarah B. is a Physician-Scientist and accomplished pediatric hematology-oncologist and clinical immunologist, currently serving as the Global Head of Cell Therapy Strategic Partnerships and Patient Operations at AstraZeneca. Previously, Sarah held roles as Vice President and Head of Clinical Development at Neogene Therapeutics and Senior Director of Clinical Development at CRISPR Therapeutics, where they led significant projects in immuno-oncology and cell therapy. Sarah's experience also includes clinical immunology leadership at various institutions and a research fellowship at Harvard Medical School, focusing on primary immunodeficiencies. With a passion for developing transformational therapies, Sarah strives to create dynamic and committed teams in the therapeutic landscape.